-
Something wrong with this record ?
The management of membranous nephropathy-an update
F. Caravaca-Fontán, GM. Fernández-Juárez, J. Floege, D. Goumenos, A. Kronbichler, K. Turkmen, C. van Kooten, E. Frangou, KI. Stevens, M. Segelmark, V. Tesar, HJ. Anders, A. Bruchfeld
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 1996 to 1 year ago
Open Access Digital Library
from 1996-01-01
PubMed
34748001
DOI
10.1093/ndt/gfab316
Knihovny.cz E-resources
- MeSH
- Adult MeSH
- Immunosuppressive Agents therapeutic use MeSH
- Kidney pathology MeSH
- Humans MeSH
- Glomerulonephritis, Membranous * diagnosis etiology therapy MeSH
- Pilot Projects MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
In recent decades, several important advances have taken place in the understanding of the pathogenesis underlying membranous nephropathy (MN) that have sparked renewed interest in its management. Four landmark trials in MN and a fifth clinical trial-which was a pilot study-have been published in recent years. The results from some of these trials have had a significant impact on the recommendations included in the 2021 Kidney Disease: Improving Global Outcomes (KDIGO) Guideline for the Management of Glomerular Diseases, representing a significant step forward compared with the previous guideline in several aspects, including diagnosis, disease monitoring and treatment strategies. However, considering the rapidly evolving advances in the knowledge of MN and the recent publication of the STARMEN and RI-CYCLO trials, several recommendations contained in the guideline warrant updates. This article provides a perspective of the Immunonephrology Working Group of the European Renal Association regarding the management of MN in native kidneys of adult patients.
Department of Health Medicine and Caring Sciences Linköping University Linköping Sweden
Department of Internal Medicine 4 Hospital of the Ludwig Maximilians University Munich Germany
Department of Medicine University of Cambridge Cambridge UK
Department of Nephrology and Renal Transplantation Patras University Hospital Patras Greece
Department of Nephrology and Transplantation Queen Elizabeth University Hospital Glasgow UK
Department of Nephrology Hospital Universitario 12 de Octubre Madrid Spain
Department of Nephrology Hospital Universitario Fundacion Alcorcon Alcorcón Spain
Division of Nephrology Department of Internal Medicine Necmettin Erbakan University Konya Turkey
Division of Nephrology RWTH Aachen University Hospital Aachen Germany
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018325
- 003
- CZ-PrNML
- 005
- 20220804134713.0
- 007
- ta
- 008
- 220720s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/ndt/gfab316 $2 doi
- 035 __
- $a (PubMed)34748001
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Caravaca-Fontán, Fernando $u Department of Nephrology, Hospital Universitario 12 de Octubre Madrid, Spain $1 https://orcid.org/0000000258309663
- 245 14
- $a The management of membranous nephropathy-an update / $c F. Caravaca-Fontán, GM. Fernández-Juárez, J. Floege, D. Goumenos, A. Kronbichler, K. Turkmen, C. van Kooten, E. Frangou, KI. Stevens, M. Segelmark, V. Tesar, HJ. Anders, A. Bruchfeld
- 520 9_
- $a In recent decades, several important advances have taken place in the understanding of the pathogenesis underlying membranous nephropathy (MN) that have sparked renewed interest in its management. Four landmark trials in MN and a fifth clinical trial-which was a pilot study-have been published in recent years. The results from some of these trials have had a significant impact on the recommendations included in the 2021 Kidney Disease: Improving Global Outcomes (KDIGO) Guideline for the Management of Glomerular Diseases, representing a significant step forward compared with the previous guideline in several aspects, including diagnosis, disease monitoring and treatment strategies. However, considering the rapidly evolving advances in the knowledge of MN and the recent publication of the STARMEN and RI-CYCLO trials, several recommendations contained in the guideline warrant updates. This article provides a perspective of the Immunonephrology Working Group of the European Renal Association regarding the management of MN in native kidneys of adult patients.
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a membranózní glomerulonefritida $x diagnóza $x etiologie $x terapie $7 D015433
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunosupresiva $x terapeutické užití $7 D007166
- 650 _2
- $a ledviny $x patologie $7 D007668
- 650 _2
- $a pilotní projekty $7 D010865
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Fernández-Juárez, Gema M $u Department of Nephrology, Hospital Universitario Fundacion Alcorcon, Alcorcón, Spain
- 700 1_
- $a Floege, Jürgen $u Division of Nephrology, RWTH Aachen University Hospital, Aachen, Germany
- 700 1_
- $a Goumenos, Dimitrios $u Department of Nephrology and Renal Transplantation, Patras University Hospital, Patras, Greece
- 700 1_
- $a Kronbichler, Andreas $u Department of Medicine, University of Cambridge, Cambridge, UK $1 https://orcid.org/0000000229452946
- 700 1_
- $a Turkmen, Kultigin $u Division of Nephrology, Department of Internal Medicine, Necmettin Erbakan University, Konya, Turkey
- 700 1_
- $a van Kooten, Cees $u Division of Nephrology and Transplant Medicine, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
- 700 1_
- $a Frangou, Eleni $u Department of Nephrology and Transplantation, Nicosia General Hospital and Medical School, University of Cyprus, Nicosia, Cyprus
- 700 1_
- $a Stevens, Kate I $u Department of Nephrology and Transplantation, Queen Elizabeth University Hospital, Glasgow, UK $1 https://orcid.org/0000000322911692
- 700 1_
- $a Segelmark, Mårten $u Division of Nephrology, Department of Clinical Sciences Lund, Lund University and Skane University Hospital, Lund, Sweden $u Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden
- 700 1_
- $a Tesar, Vladimir $u Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Anders, Hans-Joachim $u Department of Internal Medicine IV, Hospital of the Ludwig Maximilians University, Munich, Germany
- 700 1_
- $a Bruchfeld, Annette $u Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden $u Department of Renal Medicine, Karolinska University Hospital and CLINTEC Karolinska Institutet, Stockholm, Sweden $1 https://orcid.org/0000000297529941
- 773 0_
- $w MED00010288 $t Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association $x 1460-2385 $g Roč. 37, č. 6 (2022), s. 1033-1042
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34748001 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134707 $b ABA008
- 999 __
- $a ok $b bmc $g 1822093 $s 1169568
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 37 $c 6 $d 1033-1042 $e 20220525 $i 1460-2385 $m Nephrology, dialysis, transplantation $n Nephrol Dial Transplant $x MED00010288
- LZP __
- $a Pubmed-20220720